Search

Author/Creator Su, H

1. 286PFirst china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics). (25th November 2018)

Authors:
Shi, Y; Zhang, Q; Han, X; Song, Y; Qin, Y; Hong, X; Ke, X; Feng, J; Wang, D; Li, W; Su, H; Zhang, Y; Zhang, H; Yang, J; Liu, L; Zhang, X; Liu, E; Jiang, W; Liu, S; Luk, A
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Galactic synchrotron distribution derived from 152 H ii region absorption features in the full GLEAM survey. Issue 3 (29th June 2018)

Authors:
Su, H; Macquart, J P; Hurley-Walker, N; McClure-Griffiths, N M; Jackson, C A; Tingay, S J; Tian, W W; Gaensler, B M; McKinley, B; Kapińska, A D; Hindson, L; Hancock, P; Wayth, R B; Staveley-Smith, L; Morgan, J; Johnston-Hollitt, M; Lenc, E; Bell, M E; Callingham, J R; Dwarkanath, K S
Journal:
Monthly notices of the Royal Astronomical Society
Issue:
Volume 479:Issue 3(2018)
Page Start:
4041
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗